Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$1.28 - $1.65 $16,802 - $21,659
13,127 New
13,127 $19,000
Q3 2021

Nov 12, 2021

SELL
$3.4 - $4.24 $34,163 - $42,603
-10,048 Closed
0 $0
Q2 2021

Aug 12, 2021

SELL
$3.76 - $5.14 $7,696 - $10,521
-2,047 Reduced 16.92%
10,048 $43,000
Q1 2021

May 14, 2021

BUY
$4.81 - $8.74 $58,176 - $105,710
12,095 New
12,095 $61,000

Others Institutions Holding MNOV

About MEDICINOVA INC


  • Ticker MNOV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 49,046,200
  • Market Cap $106M
  • Description
  • MediciNova, Inc., a biopharmaceutical company, focuses on developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs in the United States. The company is developing MN-166 (ibudilast), an oral anti-inflammatory and neuroprotective agent for treating neurological disorders, such as primary and ...
More about MNOV
Track This Portfolio

Track Xtx Topco LTD Portfolio

Follow Xtx Topco LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Xtx Topco LTD, based on Form 13F filings with the SEC.

News

Stay updated on Xtx Topco LTD with notifications on news.